Can I Sell Peptides on Shopify or WooCommerce?

As software, yes — both are general-purpose commerce platforms, and neither is built specifically to permit or block a research-peptide catalog. The decision almost never turns on the storefront itself. It turns on three layers stacked underneath it: the platform's current acceptable use terms, the payment processor's underwriting appetite for your product category, and your own regulatory posture as the seller. Get the middle layer wrong and a technically functional store stops accepting money on a Tuesday morning with no warning and no appeal window you control.

So the useful version of this question is not "which platform allows it." It is "which stack survives underwriting review, and what documentation do I need behind every product page to keep it there."

The gatekeeper is the money, not the cart

A storefront platform gives you a catalog, a cart, a checkout page, and an order record. It does not move funds. Funds move through a payment gateway, an acquiring bank, and the card networks — and each of those parties applies its own risk classification to what you sell.

There are broadly two ways to get card acceptance, and the difference matters more than any theme or plugin choice.

Aggregated or built-in processing onboards you in minutes because you are placed under a shared master merchant arrangement. Speed is the feature; exclusion is the risk control. Aggregators manage portfolio risk by declining or removing whole categories, and that review can happen after you have been selling for months. Consequences can include held payouts, a rolling reserve against future settlements, or account closure.

A dedicated merchant account underwritten for higher-risk categories takes longer, asks for far more documentation, and typically carries different pricing. In exchange, someone at the acquirer has actually read your business description, looked at your site, and priced the risk deliberately rather than by category default.

Underwriters generally want to see the same things: a clear description of what you sell and to whom, your entity and ownership documents, processing history if you have it, a refund and returns policy that a cardholder could actually follow, contact information that resolves to a real human, and a site whose marketing language matches the business description you submitted. That last point is where most applications quietly fail — the application says "research materials sold to businesses" and the homepage reads like consumer health copy.

One structural detail worth understanding before you pick a path: when a processor terminates a merchant for cause, it may report that termination to industry databases used by other acquirers during underwriting. Being listed makes future approvals harder and slower. Ask any prospective processor directly how it handles category reviews, what would trigger a reserve, what notice you receive, and under what circumstances a termination gets reported. Put the answers in writing before you migrate a catalog.

Hosted platform or self-hosted software: what each layer controls

Both options can host a compliant, well-documented research-materials catalog. They distribute control and burden differently.

The practical read: a hosted platform trades some autonomy for operational simplicity, and a self-hosted stack trades simplicity for control over the payment relationship. Neither removes the underwriting question, because the acquirer evaluates your business, not your CMS.

Read the policy layer yourself, and date what you read

Platform acceptable use policies, restricted business lists, gateway prohibited-product lists, app and integration terms, email and SMS provider policies, and advertising platform policies are all separate documents maintained by separate companies. They are revised without notice, they are not consistent with each other, and the strictest one governs your practical reality — often the gateway's, not the platform's.

Do not rely on a forum post, a competitor's live store, or a summary written last year. Open the current documents, read the sections that touch supplements, chemicals, health products, and regulated goods, and keep a dated record of what they said on the day you reviewed them. Re-check before every material catalog expansion. Your email provider may refuse to send campaigns your platform would happily host; your ad account may reject creative your checkout accepts.

Questions to resolve with counsel before you launch

This section is informational and is not legal advice. The point is to know which questions belong to your attorney rather than to a platform help article.

• How is each item in your intended catalog classified for a business like yours, and does that classification change with how you describe, label, or market it?
• What entity registrations, business licenses, or board notifications, if any, apply to a reseller in the states you ship to — and does your state board treat a reseller differently from a practice? Check with your state board and your attorney rather than assuming.
• Who is the responsible party for labeling and documentation on a product you resell but did not manufacture?
• What claims, if any, may appear anywhere on your domain — including blog posts, meta descriptions, image alt text, packing inserts, and customer email templates?
• What records must you retain per order and per lot, and for how long?
• How should returns, disputes, and destruction of returned material be handled?
• What does your insurance actually cover for this category?

Anyone who answers these for you in a sentence, without asking about your entity, your catalog, and your states, is guessing. A precise-sounding answer from a supplier is not a legal opinion.

Building product pages that don't create their own problems

Most avoidable trouble in this category is self-inflicted through copy. Research-use-only framing has to be consistent across the entire property, not just on a disclaimer page nobody reads.

That means no dosing figures, administration instructions, reconstitution walkthroughs, or protocol content anywhere on the domain — including educational blog content, FAQs, and email sequences. It means not pairing compounds with supplies in a way that reads as a ready-to-use kit. It means moderating third-party review widgets and comment sections, because user-generated content on your domain becomes part of your marketing surface. And it means checking that SEO-driven copy, written months ago by someone else, hasn't drifted into language your compliance page contradicts.

Product data deserves the same discipline: unambiguous product names, lot-level identification, and a documented, findable path from a product page to the certificate of analysis for the material you actually shipped. A COA link that leads to a generic "representative" document is a documentation gap you will feel during a dispute.

Operations behind the checkout button

A storefront is the easy half. The half that determines whether the business is workable is fulfillment and records.

Work out, before launch, how lot numbers flow from receiving into inventory and onto the order record; how you pull the correct COA for a given lot months later; how you verify that a buyer is the kind of buyer you intend to serve; how chargeback responses get assembled from order, shipping, and delivery evidence; how returns are handled and documented; and how handling requirements are met in transit. Each of these is boring until the first dispute, at which point they are the entire case.

Your storefront inherits your supplier's paperwork

Everything above depends on documentation you do not produce. When a customer, a processor, or a regulator asks what a product is and how you know, your answer is only as good as what your supplier hands you.

Before you commit a catalog to a supplier, verify: what analytical method establishes purity and at what threshold; what tests exist beyond purity; whether the certificate is specific to the lot you receive rather than a representative sample; whether you can see COAs before buying or only after; whether wholesale pricing is visible or gated behind a sales call; where fulfillment originates and how order minimums are structured.

Industry practices worth avoiding are easy to spot once you look for them: pricing that never appears in writing, COAs sold separately or withheld until after payment, testing claims with no named method and no document behind them, and lot documentation that cannot be matched to the material in the box.

What Real Peptides does differently

Real Peptides supplies research-use-only peptides to businesses through its Wholesale Partner Program, and the documentation posture is built for buyers who have to answer questions about their catalog.

Material is tested to 99%+ HPLC purity, with 6-panel batch testing behind each lot rather than a single purity figure standing in for a full picture. Certificates of analysis are publicly verifiable — a prospective partner can check the lab results directly before applying, not after paying, and not as a paid add-on. Fulfillment is US-based with orders shipping in 5–7 days, so inventory planning is not hostage to an overseas transit estimate. Access runs through a 3-step wholesale application rather than an indefinite sales process.

None of that resolves your platform question for you. It does mean the documentation layer under your product pages exists, is lot-specific, and can be shown to a customer or a processor without a request to the supplier.

If you are building a store on either platform and want a supply relationship whose paperwork holds up under scrutiny, review the program terms and submit the application — approval is based on the business, so the fastest way to a real answer is a completed application rather than an inquiry.

For pricing structure, catalog scope, and account terms, see the wholesale peptides program overview, or apply for a wholesale account to start the three-step review.